Navigation Links
Zimmer Holdings to Present at Merrill Lynch Health Care Conference
Date:1/29/2008

WARSAW, Ind., Jan. 29 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry, announced today it will be participating in Merrill Lynch's 19th Annual Global Pharmaceutical, Biotechnology and Medical Device Conference in New York on February 5, 2008, at 8:00 a.m. Eastern Time.

A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcast will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is a worldwide leader in designing, developing, manufacturing and marketing orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of more than 7,500 employees worldwide.

Visit Zimmer on the worldwide web at http://www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmer Reports Fourth Quarter and 2007 Financial Results
2. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
3. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
4. Zimmer Holdings to Present at JPMorgan Healthcare Conference
5. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
6. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
7. Zimmer Holdings to Present at Upcoming Investor Conferences
8. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
10. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
11. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... San Francisco, CA (PRWEB) , ... January 19, 2017 , ... ... and financial planning assistance to commercial and residential clients in the California Bay Area, ... promote positive heart health in the region. , Heart disease is the primary killer ...
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Connecticut Dermatology Group ... Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background ... , “It is with considerable pleasure to welcome back Dr. Kim to the CDG ...
(Date:1/19/2017)... ... 19, 2017 , ... Each year, the Southeastern Society of ... hundreds of surgeons from over fifteen different countries come together to share and ... augmentation to breast reconstruction for breast cancer patients, teaching these surgical techniques ...
(Date:1/18/2017)... ... 2017 , ... From a health perspective, 2017 will clearly be the Year ... chronic disease, mental health and general physical well-being. The New York Times suggested a ... , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  ViewRay, Inc. (Nasdaq: VRAY ... clinical MRI-guided radiation therapy system, announced today that it ... million through a private placement of its common ... financing and was joined by certain of ViewRay,s ... Venture Partners, and an additional new institutional investor, ...
(Date:1/19/2017)... ROCKVILLE, Md. , Jan. 18, 2017 /PRNewswire/ ... a late-stage clinical company developing therapeutics designed to ... health of patients, today confirmed plans to initiate ... the Company,s modified-release reformulation of lovastatin lactone designed ... M. smithii) in the gut to treat ...
Breaking Medicine Technology: